金沙6165总站线路检测(中国)有限公司

Home

CRO Services

Disease Models and Pharmacodynamics

Ophthalmic Disease

CNS Disease

Metabolic Disease

CVD and Other Disease

Regulatory Strategies and Safety Assessment

Regulatory Strategy

Drug Metabolism and Pharmacokinetics

Drug Safety Assessment

Safety Assessment of Medical Devices

Clinical Trials and
Laboratory Services

Clinical Trials

Laboratory Services

Technical platform and instrument Bioanalysis Biomarker Clinical and Molecular Pathology Laboratory

鼎泰愿景

Innovative CRO enabling new drug R&D in disease-oriented fields

Disease-Oriented R&D

Ophthalmology

In vivo Ocular Disease Models

Ocular Routes of Administration

Clinical Ophthalmology Examinations

Bioanalysis of Eye Tissues

Ophthalmology Pathology Evaluation

Clinical Service

CNS

Disease Models

Drug Safety Assessment

Clinical Research Services

Clinical Research Services

Project Experience

Innovation

iPSCs & Organoids Evaluation Department

Cell Biology & Immunology Evaluation Department

鼎泰愿景

To build an international drug evaluation platform for ophthalmic /CNS/ metabolic disease

News&Insight

Top News Latest Industry News Thoughts and Insights Important Events Video Class Q&A

鼎泰愿景

Witness the development of industry innovation, share TriApex exclusive insights

投资者关系

公告及通函公司治理推介材料投资者联系方式

鼎泰愿景

打造符合国际标准国内一流的CRO
“生物经济”产业生态圈

About us

TriApex Profile Credibility Qualification Social Responsibility Join us

鼎泰愿景

Dedicated to scientific assessment, enabling transformation of innovation, and improving quality of life

Global

En Cn

Disease-oriented
R&D